Does Your Product Contain Methylene Diphenyl Diisocyanates (MDI)?

By: Ivy Tang, Product Safety Specialist, email

In May 2019, five MDIs (methylene diphenyl diisocyanates) were added to Schedule 1 of the List of Toxic Substances of the Canadian Environmental Protection Act (CEPA 1999). The Government of Canada concluded that the MDIs met the criterion in CEPA Paragraph 64(c) and constitute a danger to human life and health. MDIs are often found in polyurethane foams, coatings, adhesives, sealants, and other ‘DIY products,’ thus exposing consumers to health risks including respiratory problems, irritation, and cancer.

The Government of Canada is proposing to partner with industry and retail to reduce MDI exposure. If you are a vendor supplying products containing at least one of the five MDIs listed below, be prepared for your Retailer to approach you. In the meantime, it is advised that you review your product listings or consult with your manufacturer, and ensure you have the correct safety warnings and labels.

[table id=12 /]

For more information regarding MDIs or Canada’s Chemical Management Plan (CMP), contact Dell Tech.

Contact:
Dell Tech Laboratories
Ivy Tang, B.Sc.
Product Safety Specialist
itang@delltech.com
519-858-5021 ext 2043


Dell Tech has provided professional, confidential consulting services to the chemical specialty industry in Canada, the USA, Europe, and Asia for the last 40 years.
Contact us today for more information.

www.delltech.com

SHARE:

Recent Posts

image

Take Your Canadian Natural Health Products to Global Markets: ITCs and GMP Certificates from Dell Tech 

Canada has a well-established regulatory framework for Natural Health Products (NHPs), with Health Canada's Natural and Non-prescription Health Products Directorate (NNHPD) overseeing product licensing, site licensing and Good Manufacturing Practices…
image

Health Canada Signals a Clear Message for Class III & IV Medical Device Applications: Quality Over Volume 

Health Canada has recently published a new Notice to Industry outlining its expectations for information submitted with Class III and Class IV Medical Device Licence Applications (MDLs). The message is…
image

Addition of R-ICL substances to the Domestic Substances List

Health Canada has recently updated its information on the Revised In Commerce List (R-ICL), which contains substances that were used in products regulated under the Food and Drugs Act and…

Have Questions About Regulatory Compliance?

If you’re unsure what your next steps should be, check our frequently asked questions page or contact us today.